SIMCERE PHARMACEUTICAL GROUP Retained Earnings
SIMCERE PHARMACEUTICAL GROUP had Retained Earnings of CNY 1.25 billion as of 2012-12-31, per its 20-F filed 2013-04-26.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2013-04-26
- 2012-12-31: Retained Earnings (Accumulated Deficit) 1.25B CNY.
- 2011-12-31: Retained Earnings (Accumulated Deficit) 1.20B CNY.
- 2010-12-31: Retained Earnings (Accumulated Deficit) 1.02B CNY.
CNY
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2012-12-31 | 1.25B CNY 20-F · filed 2013-04-26 |
| 2011-12-31 | 1.20B CNY 20-F · filed 2013-04-26 |
| 2010-12-31 | 1.02B CNY 20-F · filed 2012-04-25 |
USD
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2012-12-31 | $201.35M 20-F · filed 2013-04-26 |